Upexi, Inc. (NASDAQ:UPXI) Director Purchases $62,590.00 in Stock

Upexi, Inc. (NASDAQ:UPXI - Get Free Report) Director Lawrence Dugan purchased 11,000 shares of the company's stock in a transaction dated Wednesday, July 16th. The shares were purchased at an average cost of $5.69 per share, for a total transaction of $62,590.00. Following the transaction, the director directly owned 112,389 shares in the company, valued at approximately $639,493.41. The trade was a 10.85% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Lawrence Dugan also recently made the following trade(s):

• On Tuesday, July 22nd, Lawrence Dugan acquired 4,000 shares of Upexi stock. The stock was purchased at an average price of $7.50 per share, for a total transaction of $30,000.00.
• On Tuesday, July 15th, Lawrence Dugan acquired 1,000 shares of Upexi stock. The shares were acquired at an average cost of $5.17 per share, for a total transaction of $5,170.00.

Upexi Stock Down 3.8%

Shares of NASDAQ:UPXI traded down $0.23 during midday trading on Monday, reaching $5.88. 8,314,196 shares of the company traded hands, compared to its average volume of 12,209,046. Upexi, Inc. has a 12 month low of $1.90 and a 12 month high of $22.57. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.24 and a current ratio of 0.37. The firm's fifty day moving average price is $7.96 and its two-hundred day moving average price is $5.96.

Upexi (NASDAQ:UPXI - Get Free Report) last posted its earnings results on Friday, May 16th. The company reported ($2.87) earnings per share (EPS) for the quarter. Upexi had a negative return on equity of 535.19% and a negative net margin of 135.86%. The firm had revenue of $3.16 million during the quarter.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Cantor Fitzgerald upgraded shares of Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 target price for the company in a research note on Monday, June 16th. Wall Street Zen upgraded shares of Upexi to a "hold" rating in a research note on Friday, May 30th.

Institutional Investors Weigh In On Upexi

Institutional investors and hedge funds have recently made changes to their positions in the business. Bank of Montreal Can bought a new position in Upexi in the 4th quarter worth about $36,000. Kathmere Capital Management LLC purchased a new position in shares of Upexi during the second quarter worth about $6,535,000. Finally, North Star Investment Management Corp. bought a new position in shares of Upexi in the second quarter worth approximately $45,000. Hedge funds and other institutional investors own 5.68% of the company's stock.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.